摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 3-O-benzyl-2,6-dideoxy-2,6-imino-α-D-mannofuranoside | 105285-30-1

中文名称
——
中文别名
——
英文名称
methyl 3-O-benzyl-2,6-dideoxy-2,6-imino-α-D-mannofuranoside
英文别名
(1S,4R,5R,7S,8R)-7-methoxy-8-phenylmethoxy-6-oxa-2-azabicyclo[3.2.1]octan-4-ol
methyl 3-O-benzyl-2,6-dideoxy-2,6-imino-α-D-mannofuranoside化学式
CAS
105285-30-1
化学式
C14H19NO4
mdl
——
分子量
265.309
InChiKey
CNXGFXJIAULZEQ-ITGHMWBKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    425.1±45.0 °C(Predicted)
  • 密度:
    1.25±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    60
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Treatment of energy utilization disease
    申请人:Vida Pharma Limited
    公开号:US10842784B2
    公开(公告)日:2020-11-24
    Described are compositions comprising imino sugar acids for the treatment of energy utilization disease (e.g. metabolic syndrome, including any disease or disorder associated therewith, for example central obesity, elevated levels of triglycerides and diabetes, including type 1 diabetes, type 2 diabetes and insulin resistance), processes for producing said compositions from various plant sources, together with various products, compounds, compositions, medical uses and methods based thereon.
    所描述的是包含亚氨基糖酸的组合物,用于治疗能量利用疾病(例如代谢综合征,包括与之相关的任何疾病或紊乱,例如中心性肥胖、甘油三酯水平升高和糖尿病,包括 1 型糖尿病、2 型糖尿病和胰岛素抵抗);从各种植物来源生产所述组合物的工艺,以及基于此的各种产品、化合物、组合物、医疗用途和方法。
  • TREATMENT OF ENERGY UTILIZATION DISEASE
    申请人:Summit Corporation Plc
    公开号:EP2257286B1
    公开(公告)日:2016-12-28
  • Treatment of Energy Utilization Disease
    申请人:Nash Robert James
    公开号:US20110015226A1
    公开(公告)日:2011-01-20
    Described are compositions comprising imino sugar acids for the treatment of energy utilization disease (e.g. metabolic syndrome, including any disease or disorder associated therewith, for example central obesity, elevated levels of triglycerides and diabetes, including type 1 diabetes, type 2 diabetes and insulin resistance), processes for producing said compositions from various plant sources, together with various products, compounds, compositions, medical uses and methods based thereon.
  • [EN] TREATMENT OF ENERGY UTILIZATION DISEASE<br/>[FR] TRAITEMENT D'UNE MALADIE DE L'UTILISATION D'ÉNERGIE
    申请人:SUMMIT CORP PLC
    公开号:WO2009103953A1
    公开(公告)日:2009-08-27
    Described are compositions comprising imino sugar acids for the treatment of energy utilization disease (e.g. metabolic syndrome, including any disease or disorder associated therewith, for example central obesity, elevated levels of triglycerides and diabetes, including type 1 diabetes, type 2 diabetes and insulin resistance), processes for producing said compositions from various plant sources, together with various products, compounds, compositions, medical uses and methods based thereon.
  • Methyl 2-azido-3-O-benzyl-2-deoxy-α-D-mamnofuranoside as a divergent intermediate for the synthesis of polyhydroxylated piperidines and pyrrolidines: synthesis of 2,5-dideoxy-2,5-imino-D-mannitol [2R,5R-dihydroxymethyl-3R,4R-dihydroxypyrrolidine]
    作者:George W.J. Fleet、Paul W. Smith
    DOI:10.1016/s0040-4020(01)90034-1
    日期:1987.1
查看更多